The largest database of trusted experimental protocols

Enterococcus faecalis

Sourced in United States, Germany, Malaysia

Enterococcus faecalis is a Gram-positive, facultatively anaerobic bacterium. It is commonly found in the human gastrointestinal tract and is known for its ability to survive in diverse environments.

Automatically generated - may contain errors

171 protocols using enterococcus faecalis

1

Microorganism Strains for Antibacterial Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Test microorganism strains that were used in this study include Bacillus cereus ATCC 14579, Bacilus subtilis ATCC 8188, Enterococcus faecalis ATCC 700802, Enterococcus faecalis ATCC 29212, Enterococcus faecalis JH-22, Staphylococcus aureus ATCC 700699, Staphylococcus aureus ATCC 43300, Staphylococcus aureus ATCC 6538P, Staphylococcus aureus ATCC 29213, Aeromonas hydrophila ATCC 49140, Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 10031, Proteus mirabilis ATCC 49140, Proteus vulgaris (Institute of Medical Research, Malaysia), Pseudomonas aeruginosa ATCC 10145, Pseudomonas aeruginosa ATCC BAA-47, Salmonella Typhimurium ATCC 14028, and Shigella flexneri ATCC 12022. Strains were cultured on Muller Hinton borth (MHB) (Oxoid, UK) at 37°C and maintained at −80°C in MHB with 25% (v/v) glycerol.
+ Open protocol
+ Expand
2

Microbial Strain Collection for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial strains (Bifidobacterium adolescentis Ni,29c (clinical isolate), Bifidobacterium breve (from probiotic VSL#3) and Streptococcous salivarius ssp. thermophiles DSM 20617 were obtained from Ardeypharm (Germany). Escherichia coli ATCC 25922, Escherichia coli K12, Pseudomonas aeruginosa ATCC 27853, Candida albicans ATCC 10231, Enterococcus faecalis ATCC 29212 as well as antibiotic-resistant clinical isolates of Acinetobacter baumannii, Enterococcus faecalis, Enterococcus faecium, Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa were provided by the Department for Laboratory Medicine at Robert-Bosch-Hospital Stuttgart, Germany. Candida albicans SC5314 was obtained from Salomé LeibundGut-Landmann (Institute of Immunology, Vetsuisse Faculty, University of Zürich, Switzerland).
+ Open protocol
+ Expand
3

Antibiotic Susceptibility of Bacterial Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
For this study, seventeen type strains: Staphylococcus aureus (ATCC 29737), S. aureus (NCTC 6571), Streptococcus pyogenes (ATCC 12344), S. pneumonia (ATCC 10015), S. agalactiae (ATCC12386), Enterococcus faecalis (ATCC 19433), E. faecalis (ATCC 49532), Salmonella typhimurium (ATCC 14028), Pseudomonas aeruginosa (ATCC 10145), Staphylococcus haemolyticus (ATCC 29970), Proteus mirabilis (NCIMB 13283), Enterobacter Aerogenes (ATCC13048), E. aerogenes (NCIMB 10102), Bacillus subtilis (ATCC 11774), Klebsiella pneumonia (ATCC 9633), Bacillus cereus (ATCC 10876) and Staphylococcus epidermidis (ATCC 12228) were examined. In addition, 10 clinical isolates of S. aureus, S. typhimurium, E. coli, S. pneumonia and K. pneumonia were also used. To verify the accuracy of the susceptibility results, strains of Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), Staphylococcus aureus (ATCC 29213) and Enterococcus faecalis (ATCC 29212) were used as control organisms.
+ Open protocol
+ Expand
4

Antimicrobial Efficacy of Novel Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bacteria strains used were Staphylococcus aureus (ATCC 29213), S. aureus (MRSA) (NCTC 12493), Enterococcus faecalis (ATCC 29212), Enterococcus faecalis (ATCC 49532), Pseudomonas aeruginosa (ATCC 27853), Escherichia coli (ATCC 25922), E. coli (NCTC 11954), and Klebsiella pneumoniae (ATCC700603).
+ Open protocol
+ Expand
5

Antibacterial Efficacy of Novel Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bacteria strains used were Staphylococcus aureus (ATCC 29213), S. aureus (MRSA) (NCTC 12493), Enterococcus faecalis (ATCC 29212), Enterococcus faecalis (ATCC 49532), Pseudomonas aeruginosa (ATCC 27853), Escherichia coli (ATCC 25922), E. coli (NCTC 11954), and Klebsiella pneumoniae (ATCC700603).
+ Open protocol
+ Expand
6

Microbial Growth Protocols for Antibacterial and Antifungal Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bacterial and fungal strains were obtained from the American Type Culture Collection (ATCC) and from the microbiology laboratory of the University of Québec in Trois-Rivières (UQTR). The microorganisms used were Escherichia coli (ATCC 35218), Salmonella enterica (ATCC 10708), Pseudomonas aeruginosa (ATCC 15442), Staphylococcus aureus (ATCC 6538), Enterococcus faecalis (ATCC 29212), Aspergillus niger (ATCC 10535), Candida albicans (from UQTR microbiology laboratory), Saccharomyces cerevisiae (from UQTR microbiology laboratory). The bacterial strains were grown on sterilized Mueller Hinton agar and incubated at 37 °C for 24 h, while the fungal strains were grown on Sabouraud dextrose agar and incubated at 37 °C for 72 h before use.
+ Open protocol
+ Expand
7

Microorganisms from ATCC for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
The microorganisms used in this study were obtained from the American Type Culture Collection (ATCC). They included five strains Enterococcus faecalis ATCC 29212, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 25923, Saccharomyces cerevisiae ATCC 2601, Staphylococcus aureus. CIP were obtained from the CIP 106760, and the yeast strain Candida albicans ATCC 10231.
+ Open protocol
+ Expand
8

Characterization of Pathogenic Microbes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Escherichia coli O157:H7 ATCC 35150, Enterococcus faecalis ATCC 29212, Listeria monocytogenes ATCC 7644, Klebsiella pneumoniae ATCC 13833, Pseudomonas aeruginosa ATCC 9027, Staphylococcus aureus ATCC 43387, Salmonella enteritidis ATCC 13076 and Candida albicans ATCC 14053 were the reference human pathogens used in this study (American Type Culture Collection, USA). All strains were maintained in Tryptic Soy Agar (TSA, Oxoid, Milan, Italy) at 37 °C, while C. albicans ATCC 14053 was grown in Sabouraud Dextrose Agar (SDA, Oxoid). All stock cultures were kept at −80 °C in nutrient broth with glycerol 15%.
+ Open protocol
+ Expand
9

Antimicrobial Effects of Chitosan-Metal Composites

Check if the same lab product or an alternative is used in the 5 most similar protocols
The growth inhibition effect of the chitosan–metal composites was tested against a range of microorganisms that acted as model organisms for gut microflora of livestock gastrointestinal tract. E. coli (ATCC 8739) and Staphylococcus aureus (ATCC 25923) were grown in tryptic soy media (Sigma-Aldrich). Enterococcus faecalis (ATCC 29212) was grown in brain heart infusion (BHI) media (BD Biosciences). Lactobacillus fermentum (ATCC 9338) was grown in MRS medium (BD Biosciences). All incubations were done at 37°C.
+ Open protocol
+ Expand
10

Antimicrobial Effects of Essential Oils

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effects of EOs were evaluated on 13 bacterial strains and 5 yeasts: Staphylococcus aureus (209 PCIP 53156), S. aureus (ATCC 29213), Micrococcus luteus (ATCC381), Bacillus cereus (ATCC 14579), Escherichia coli (ATCC 8739), E. coli (ATCC 35214), Pseudomonas aeruginosa (DSM 50090), P. aeruginosa (ATCC 27853), Klebsiella pneumoniae (CIP 104727), K. pneumoniae (clinical isolates), Enterococcus faecalis (ATCC 29212), Listeria monocytogenes (ATCC 19115), Salmonella enteritidis (DMB 560), Candida albicans (CCMM L4), C. krusei (CCMM L10), C. glabrata (CCMM L7), C. parapsilosis (CCMM L18) and Aspergilus niger (CCMM M100). The bacterial and yeast strains were provided by the Center of Biotechnology, Borj Cedria, Tunisia.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!